JP2017519768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017519768A5 JP2017519768A5 JP2016573926A JP2016573926A JP2017519768A5 JP 2017519768 A5 JP2017519768 A5 JP 2017519768A5 JP 2016573926 A JP2016573926 A JP 2016573926A JP 2016573926 A JP2016573926 A JP 2016573926A JP 2017519768 A5 JP2017519768 A5 JP 2017519768A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- antibody
- binding fragment
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462014506P | 2014-06-19 | 2014-06-19 | |
| US62/014,506 | 2014-06-19 | ||
| US201562140849P | 2015-03-31 | 2015-03-31 | |
| US62/140,849 | 2015-03-31 | ||
| PCT/US2015/036576 WO2015196011A1 (en) | 2014-06-19 | 2015-06-19 | Treatment of polybacterials infections |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020209896A Division JP2021063090A (ja) | 2014-06-19 | 2020-12-18 | 多細菌性感染の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017519768A JP2017519768A (ja) | 2017-07-20 |
| JP2017519768A5 true JP2017519768A5 (enExample) | 2018-08-09 |
| JP6845016B2 JP6845016B2 (ja) | 2021-03-17 |
Family
ID=54936121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573926A Active JP6845016B2 (ja) | 2014-06-19 | 2015-06-19 | 多細菌性感染の治療 |
| JP2020209896A Pending JP2021063090A (ja) | 2014-06-19 | 2020-12-18 | 多細菌性感染の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020209896A Pending JP2021063090A (ja) | 2014-06-19 | 2020-12-18 | 多細菌性感染の治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11168132B2 (enExample) |
| EP (1) | EP3157565B1 (enExample) |
| JP (2) | JP6845016B2 (enExample) |
| KR (1) | KR102549870B1 (enExample) |
| CN (1) | CN106456767B (enExample) |
| AU (1) | AU2015276938B2 (enExample) |
| CA (1) | CA2952278A1 (enExample) |
| ES (1) | ES2983252T3 (enExample) |
| SG (2) | SG11201609652RA (enExample) |
| TW (1) | TWI719938B (enExample) |
| WO (1) | WO2015196011A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012267732A1 (en) | 2011-06-10 | 2014-01-09 | Medimmune Limited | Anti-Pseudomonas Psl binding molecules and uses thereof |
| WO2013070615A1 (en) * | 2011-11-07 | 2013-05-16 | Medlmmune, Llc. | Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| ES2912267T3 (es) | 2012-11-06 | 2022-05-25 | Medimmune Llc | Métodos de tratamiento de enfermedades asociadas a S. aureus |
| EP2917360B1 (en) * | 2012-11-06 | 2020-01-08 | Medlmmune, LLC | Antibodies to s. aureus surface determinants |
| HK1257193A1 (zh) | 2015-11-30 | 2019-10-18 | Medimmune Limited | 用於预防或治疗医源性肺炎的方法 |
| SG11201809778TA (en) | 2016-05-05 | 2018-12-28 | Univ Pennsylvania | Dna antibody constructs for use against pseudomonas aeruginosa |
| TW202311284A (zh) | 2017-01-03 | 2023-03-16 | 美商再生元醫藥公司 | 抗金黃色葡萄球菌溶血素ａ毒素之人類抗體 |
| MX2021000889A (es) | 2018-07-24 | 2021-04-28 | Medimmune Llc | Anticuerpo dirigido contra el factor de agregación a (clfa) de s. aureus. |
| WO2020076790A1 (en) | 2018-10-09 | 2020-04-16 | Medimmune, Llc | Antibodies directed against staphylococcus aureus leukotoxins |
| MX2021004173A (es) | 2018-10-09 | 2021-09-08 | Medimmune Llc | Combinaciones de anticuerpos dirigidos contra staphylococcus aureus. |
| GB201816553D0 (en) | 2018-10-10 | 2018-11-28 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| GB201816554D0 (en) | 2018-10-10 | 2018-11-28 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| WO2020172233A1 (en) * | 2019-02-22 | 2020-08-27 | The Trustees Of Columbia University In The City Of New York | Treatment of prostate cancer by androgen ablation and il-8 blockade |
| JP7682795B2 (ja) * | 2019-03-13 | 2025-05-26 | メディミューン，エルエルシー | コロニー形成患者における黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症の低減 |
| CN113966343A (zh) * | 2019-06-11 | 2022-01-21 | 瑞泽恩制药公司 | 结合PcrV的抗PcrV抗体、包含抗PcrV抗体的组合物及其使用方法 |
| JP7774293B2 (ja) * | 2019-07-24 | 2025-11-21 | 国立研究開発法人科学技術振興機構 | 抗体酵素の革新的製造技術 |
| FR3114970B1 (fr) * | 2020-10-08 | 2023-06-30 | Univ Tours | Combinaison d’anticorps inhalés avec des agents immunomodulateurs pour le traitement ou la prévention d’inféctions respiratoires |
| WO2025117765A1 (en) * | 2023-12-01 | 2025-06-05 | University Of Washington | Protective monoclonal antibodies to pseudomonas aeruginosa |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009539979A (ja) | 2006-06-12 | 2009-11-19 | ナビ バイオファーマシューティカルズ | ブドウ球菌感染症を治療および予防するための、α毒素の使用 |
| EP2515935A4 (en) | 2009-12-22 | 2013-08-28 | Kalobios Pharmaceuticals Inc | METHOD FOR TREATING STAPHYLOCOCCUS INFECTION IN A PATIENT WITH PSEUDOMONAS AERUGINOSA INFECTION WITH LOW PATHOGEN LEVEL |
| RS58190B2 (sr) * | 2011-02-08 | 2021-08-31 | Medimmune Llc | Antitela koja specifično vezuju staphylococcus aureus alfa toksin i postupci njihove primene |
| WO2013070615A1 (en) | 2011-11-07 | 2013-05-16 | Medlmmune, Llc. | Combination therapies using anti- pseudomonas psl and pcrv binding molecules |
| US20150284450A1 (en) * | 2012-11-06 | 2015-10-08 | Medimmune, Llc | Combination therapies using anti-pseudomonas psl and pcrv binding molecules |
| EP2917360B1 (en) | 2012-11-06 | 2020-01-08 | Medlmmune, LLC | Antibodies to s. aureus surface determinants |
| ES2912267T3 (es) | 2012-11-06 | 2022-05-25 | Medimmune Llc | Métodos de tratamiento de enfermedades asociadas a S. aureus |
| US20190077851A1 (en) | 2015-10-30 | 2019-03-14 | Bruno Francois | Methods of using anti-alpha toxin antibody |
-
2015
- 2015-06-18 TW TW104119861A patent/TWI719938B/zh active
- 2015-06-19 US US15/319,958 patent/US11168132B2/en active Active
- 2015-06-19 ES ES15809174T patent/ES2983252T3/es active Active
- 2015-06-19 SG SG11201609652RA patent/SG11201609652RA/en unknown
- 2015-06-19 KR KR1020167034742A patent/KR102549870B1/ko active Active
- 2015-06-19 EP EP15809174.4A patent/EP3157565B1/en active Active
- 2015-06-19 AU AU2015276938A patent/AU2015276938B2/en active Active
- 2015-06-19 CA CA2952278A patent/CA2952278A1/en active Pending
- 2015-06-19 JP JP2016573926A patent/JP6845016B2/ja active Active
- 2015-06-19 WO PCT/US2015/036576 patent/WO2015196011A1/en not_active Ceased
- 2015-06-19 SG SG10201811361XA patent/SG10201811361XA/en unknown
- 2015-06-19 CN CN201580032548.7A patent/CN106456767B/zh active Active
-
2020
- 2020-12-18 JP JP2020209896A patent/JP2021063090A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021063090A5 (enExample) | ||
| JP6845016B2 (ja) | 多細菌性感染の治療 | |
| DiGiandomenico et al. | Antibacterial monoclonal antibodies: the next generation? | |
| US11911472B2 (en) | Monoclonal antibody and vaccine targeting filamentous bacteriophage | |
| Sulakvelidze et al. | Bacteriophages as therapeutic agents | |
| Munita et al. | Enterococcal endocarditis: can we win the war? | |
| JP2016507470A5 (enExample) | ||
| JP2013515079A5 (enExample) | ||
| HRP20201370T1 (hr) | Kombinacijske terapije koje koriste anti-pseudomonas psl i pcrv vezujuće molekule | |
| Bezáková et al. | Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants | |
| JP2022512647A5 (enExample) | ||
| RU2016116949A (ru) | Анти-лпс о11-антитело | |
| JP2022536469A5 (enExample) | ||
| JP2018529661A5 (enExample) | ||
| JP2015536951A5 (enExample) | ||
| CN111372603A (zh) | 针对铜绿假单胞菌感染的组合物和方法 | |
| WO2020201833A8 (en) | Gepotidacin for use in the treatment of bacterial urinary tract infections | |
| JP2012516897A5 (enExample) | ||
| US20060153857A1 (en) | Method of treating staphylococcus aureus infection | |
| Tur | Clinical Microbiology and Infectious Diseases (ECCMID)-28th European Congress. Madrid, Spain-April 21-24, 2018 | |
| Kim et al. | Infective endocarditis prophylaxis before dental procedures: New guidelines spark controversy | |
| Projan | Antibodies for the Prevention, Treatment, and Preemption of Infectious Diseases | |
| Burkhard | Emerging therapies against infections with Pseudomonas aeruginosa | |
| Tümmler | aeruginosa [version 1; peer review: 2 approved] | |
| AI Valasidis et al. | Novel antimicrobial agents for the management of maxillofacial and neck infections |